Search

A new report from MIT suggests that universities should avoid concentrating too much on technology transfer.

Forget stem cells, pharmacogenomics and the next big cure - Michael Kenward gazes into his prophecy book to see what the physical sciences have in store for us this year. Or maybe not.

Scientists at Edinburgh University have developed a new method for cleaning surgical instruments that entirely removes protein contamination, including the near-indestructible prions - the agents that cause mad cow disease

The first investor-ready company has rolled off the production line in a scheme set up by the development agency Yorkshire Forward to commercialise research from the UK county's universities.

Charges of scientific fraud in Korea aren't likely to faze Britain's ambitious stem-cell efforts, as evidenced by plans for a £40 million lab run by the 'father' of Dolly the sheep.

The countries of Scandinavia and the Baltic have got together to maximise the value of intellectual property, the feedstock of the knowledge economy.

Lab-supply companies are normally in the business of selling things to scientists, rather than buying. But the new CEO of Sigma-Aldrich, one of the world's largest lab-supply firms, is shopping for new ideas, new partners - and new companies to invest in.

"I didn't think they would be at this stage for decades, let alone within a year." Gerald Schatten, colleague of Korea's stem-cell celebrity, before scandal broke

Sworn enemies within the technology and pharmaceutical industries are joining forces in a lobbying drive to persuade European Union lawmakers to change a draft law they say will stifle innovation in Europe by criminalising patent infringements, along with all forms of intellectual property infringements.

Diamonds are the hardest natural substance known to man, and hard to find too. But Russian scientists say they have found a way to make prospecting for the precious mineral much easier.

Cambridge University is tightening its grip on rights to intellectual property generated by staff and students after academics voted overwhelmingly to endorse new plans

On inventive Californians, technology transfer, how to approach the business press, and other insights into R&D management.

Investing in technology that's a few years from commercialisation can be tricky. Lori Valigra finds out how some venture capitalists sort the wheat from the chaff.

Cambridge University wants rights to the intellectual property generated by its staff. The idea has divided scientists in a university well known for its high-tech spin-outs.

Two New Year's resolutions for the governments around the world that have managed to gum up the economic machinery behind technological development.

Every cloud has its silver lining. So if it wasn't for his daughter's diabetes, Anders Essen-Möller might not have sold his company and started Diamyd Medical AB.

University tech transfer offices should stop trying to do the impossible, says Biofusion CEO David Baynes.